Literature DB >> 7786302

Photosensitized inhibition of growth factor-regulated protein kinases by hypericin.

P Agostinis1, A Vandenbogaerde, A Donella-Deana, L A Pinna, K T Lee, J Goris, W Merlevede, J R Vandenheede, P De Witte.   

Abstract

The naphthodianthrone hypericin causes a photosensitized inhibition of protein kinases involved in growth factor signalling pathways. Nanomolar concentrations of hypericin inhibit the protein tyrosine kinase activities (PTK) of the epidermal growth factor receptor and the insulin receptor, while being ineffective towards the cytosolic protein tyrosine kinases Lyn, Fgr, TPK-IIB and CSK. Photosensitized inhibition by hypericin is not restricted to receptor-PTKs since the Ser/Thr protein kinases (protein kinase CK-2, protein kinase C and mitogen-activated kinase) are also extremely sensitive to inhibition (IC50 value for protein kinase CK-2 = 6 nM). A comparison of the hypericin-mediated inhibition of the epidermal growth factor-receptor PTK and protein kinase CK-2 revealed that the inhibition is irreversible, strictly dependent upon irradiation of the enzyme-inhibitor complex with fluorescent light and likely mediated by the formation of radical intermediates (type I mechanism). Although the exact molecular basis for the selectivity of enzyme inhibition by hypericin remains unknown, our results suggest that distantly related protein kinases could still share common reactive domains for the interaction with hypericin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7786302     DOI: 10.1016/0006-2952(95)00097-j

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase.

Authors:  J M Jacqué; A Mann; H Enslen; N Sharova; B Brichacek; R J Davis; M Stevenson
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

2.  Regulation of Na+-K+-2Cl- cotransport by protein phosphorylation in ferret erythrocytes.

Authors:  P W Flatman; J Creanor
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

3.  Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents.

Authors:  Diane F Birt; Mark P Widrlechner; Kimberly Dp Hammer; Matthew L Hillwig; Jingqiang Wei; George A Kraus; Patricia A Murphy; Joeann McCoy; Eve S Wurtele; Jeffrey D Neighbors; David F Wiemer; Wendy J Maury; Jason P Price
Journal:  Pharm Biol       Date:  2009       Impact factor: 3.503

4.  Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase.

Authors:  K E Reed; J Xu; C M Rice
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy.

Authors:  G Lavie; C Kaplinsky; A Toren; I Aizman; D Meruelo; Y Mazur; M Mandel
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

6.  Photoactivation of hypericin decreases the viability of RINm5F insulinoma cells through reduction in JNK/ERK phosphorylation and elevation of caspase-9/caspase-3 cleavage and Bax-to-Bcl-2 ratio.

Authors:  Jingwen Yi; Xiaoguang Yang; Lihua Zheng; Guang Yang; Luguo Sun; Yongli Bao; Yin Wu; Yanxin Huang; Chunlei Yu; Shao-Nian Yang; Yuxin Li
Journal:  Biosci Rep       Date:  2015-04-20       Impact factor: 3.840

Review 7.  Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress.

Authors:  Abhishek D Garg; Hannelore Maes; Alexander R van Vliet; Patrizia Agostinis
Journal:  Mol Cell Oncol       Date:  2014-12-01

Review 8.  Antiproliferative Effects of St. John's Wort, Its Derivatives, and Other Hypericum Species in Hematologic Malignancies.

Authors:  Alessandro Allegra; Alessandro Tonacci; Elvira Ventura Spagnolo; Caterina Musolino; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2020-12-25       Impact factor: 5.923

9.  Hypericum triquetrifolium and H. neurocalycinum as Sources of Antioxidants and Multi-Target Bioactive Compounds: A Comprehensive Characterization Combining In Vitro Bioassays and Integrated NMR and LC-MS Characterization by Using a Multivariate Approach.

Authors:  Stefano Dall'Acqua; Gunes Ak; Kouadio Ibrahime Sinan; Fevzi Elbasan; Irene Ferrarese; Stefania Sut; Evren Yıldıztugay; Gregorio Peron; Elisabetta Schievano; Marie Carene Nancy Picot-Allain; Mohamad Fawzi Mahomoodally; Gokhan Zengin
Journal:  Front Pharmacol       Date:  2021-03-26       Impact factor: 5.810

10.  Hypericin, a potential new BH3 mimetic.

Authors:  Anastasia Doroshenko; Silvia Tomkova; Tibor Kozar; Katarina Stroffekova
Journal:  Front Pharmacol       Date:  2022-10-04       Impact factor: 5.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.